JAAD Case Reports (Dec 2020)
Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
- Taylor C. Duke, MD,
- Ranjit Nair, MD,
- Carlos Torres-Cabala, MD,
- Rodabe N. Amaria, MD,
- Elizabeth Keiser, MD,
- Roberto Miranda, MD,
- Swaminathan P. Iyer, MD,
- Meghan Heberton, MD
Affiliations
- Taylor C. Duke, MD
- Department of Dermatology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas
- Ranjit Nair, MD
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Carlos Torres-Cabala, MD
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Rodabe N. Amaria, MD
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Elizabeth Keiser, MD
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Roberto Miranda, MD
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Swaminathan P. Iyer, MD
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Meghan Heberton, MD
- Department of Dermatology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Correspondence to: Meghan Heberton, MD, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030.
- Journal volume & issue
-
Vol. 6,
no. 12
pp. 1264 – 1267